Diagnostika a péče u Duchennovy svalové dystrofie (diagnostika, farmakologická a psychosociální péče), část 1.
K. Bushby(Newcastle University), James Poysky(Baylor College of Medicine), David J. Birnkrant(MetroHealth Medical Center), Frederic Shapiro(Northeastern University), Linda Cripe(The Ohio State University), Carolyn M. Constantin(Centers for Disease Control and Prevention), Craig M. McDonald(University of California Davis Medical Center), Ajay Kaul(Cincinnati Children's Hospital Medical Center), Richard S. Finkel(St. Jude Children's Research Hospital), Paula R. Clemens(University of Pittsburgh), Shree Pandya(University of Rochester Medical Center), Kathi Kinnett(Cincinnati Children's Hospital Medical Center), Jean Tomezsko(Children's Hospital of Philadelphia)
Unknown
January 1, 2009
Cited by 0
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Agalsidase-Beta Therapy for Advanced Fabry Disease
|Annals of Internal Medicine|2007|565
A phase I/IItrial of MYO‐029 in adult subjects with muscular dystrophy
|Annals of Neurology|2008|466